Crossmark

Pattern of Use and Long-Term Safety of Tyrosine Kinase Inhibitors: A Decade of Real-World Management of Chronic Myeloid Leukemia

Crossref DOI link: https://doi.org/10.1007/s40261-018-0676-7

Published Online: 2018-07-24

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bettiol, Alessandra

Marconi, Ettore

Lombardi, Niccolò

Crescioli, Giada

Gherlinzoni, Filippo

Walley, Thomas

Vannacci, Alfredo

Chinellato, Alessandro

Giusti, Pietro
License Information

Text and Data Mining valid from 2018-07-24
More Information

Article History

First Online: 24 July 2018

Compliance with Ethical Standards

:

: No funding was received for this study.

: Alessandra Bettiol, Ettore Marconi, Niccolò Lombardi, Giada Crescioli, Filippo Gherlinzoni, Thomas Walley, Alfredo Vannacci, Alessandro Chinellato and Pietro Giusti declare that they have no conflicts of interest.

: The Ethics Committee of the Local Health Unit n.2 of Treviso (Regione Veneto, Comitato Etico per la Sperimentazione Clinica delle Province di Belluno e Treviso) notified the present study on 15 December 2016 (Studio n. XLV/RPA—AULSS 9—Studio Osservazionale—No Profit).

: Formal consent is not required for this type of study.